István Kenessey, Zsófia Kramer, Lilla István, Mihály T Cserepes, Tamás Garay, Balázs Hegedűs, Judit Dobos, József Tímár, József Tóvári. Melanoma Res 2018
Times Cited: 11
Times Cited: 11
Times Cited
Times Co-cited
Similarity
BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact.
Helen Rizos, Alexander M Menzies, Gulietta M Pupo, Matteo S Carlino, Carina Fung, Jessica Hyman, Lauren E Haydu, Branka Mijatov, Therese M Becker, Suzanah C Boyd,[...]. Clin Cancer Res 2014
Helen Rizos, Alexander M Menzies, Gulietta M Pupo, Matteo S Carlino, Carina Fung, Jessica Hyman, Lauren E Haydu, Branka Mijatov, Therese M Becker, Suzanah C Boyd,[...]. Clin Cancer Res 2014
36
Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
36
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
Ravid Straussman, Teppei Morikawa, Kevin Shee, Michal Barzily-Rokni, Zhi Rong Qian, Jinyan Du, Ashli Davis, Margaret M Mongare, Joshua Gould, Dennie T Frederick,[...]. Nature 2012
Ravid Straussman, Teppei Morikawa, Kevin Shee, Michal Barzily-Rokni, Zhi Rong Qian, Jinyan Du, Ashli Davis, Margaret M Mongare, Joshua Gould, Dennie T Frederick,[...]. Nature 2012
36
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.
Reinhard Dummer, Paolo A Ascierto, Helen J Gogas, Ana Arance, Mario Mandala, Gabriella Liszkay, Claus Garbe, Dirk Schadendorf, Ivana Krajsova, Ralf Gutzmer,[...]. Lancet Oncol 2018
Reinhard Dummer, Paolo A Ascierto, Helen J Gogas, Ana Arance, Mario Mandala, Gabriella Liszkay, Claus Garbe, Dirk Schadendorf, Ivana Krajsova, Ralf Gutzmer,[...]. Lancet Oncol 2018
27
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma.
Maria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, Amaya Viros, Samra Turajlic, Dan Niculescu-Duvaz, Alfonso Zambon, John Sinclair, Andrew Hayes, Martin Gore,[...]. Cancer Discov 2013
Maria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, Amaya Viros, Samra Turajlic, Dan Niculescu-Duvaz, Alfonso Zambon, John Sinclair, Andrew Hayes, Martin Gore,[...]. Cancer Discov 2013
27
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.
Chong Sun, Liqin Wang, Sidong Huang, Guus J J E Heynen, Anirudh Prahallad, Caroline Robert, John Haanen, Christian Blank, Jelle Wesseling, Stefan M Willems,[...]. Nature 2014
Chong Sun, Liqin Wang, Sidong Huang, Guus J J E Heynen, Anirudh Prahallad, Caroline Robert, John Haanen, Christian Blank, Jelle Wesseling, Stefan M Willems,[...]. Nature 2014
27
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K.
Jessie Villanueva, Adina Vultur, John T Lee, Rajasekharan Somasundaram, Mizuho Fukunaga-Kalabis, Angela K Cipolla, Bradley Wubbenhorst, Xiaowei Xu, Phyllis A Gimotty, Damien Kee,[...]. Cancer Cell 2010
Jessie Villanueva, Adina Vultur, John T Lee, Rajasekharan Somasundaram, Mizuho Fukunaga-Kalabis, Angela K Cipolla, Bradley Wubbenhorst, Xiaowei Xu, Phyllis A Gimotty, Damien Kee,[...]. Cancer Cell 2010
27
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Cory M Johannessen, Jesse S Boehm, So Young Kim, Sapana R Thomas, Leslie Wardwell, Laura A Johnson, Caroline M Emery, Nicolas Stransky, Alexandria P Cogdill, Jordi Barretina,[...]. Nature 2010
Cory M Johannessen, Jesse S Boehm, So Young Kim, Sapana R Thomas, Leslie Wardwell, Laura A Johnson, Caroline M Emery, Nicolas Stransky, Alexandria P Cogdill, Jordi Barretina,[...]. Nature 2010
27
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.
Elena Pasquali, José C García-Borrón, Maria Concetta Fargnoli, Sara Gandini, Patrick Maisonneuve, Vincenzo Bagnardi, Claudia Specchia, Fan Liu, Manfred Kayser, Tamar Nijsten,[...]. Int J Cancer 2015
Elena Pasquali, José C García-Borrón, Maria Concetta Fargnoli, Sara Gandini, Patrick Maisonneuve, Vincenzo Bagnardi, Claudia Specchia, Fan Liu, Manfred Kayser, Tamar Nijsten,[...]. Int J Cancer 2015
18
Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer.
Ryan B Corcoran, Thierry André, Chloe E Atreya, Jan H M Schellens, Takayuki Yoshino, Johanna C Bendell, Antoine Hollebecque, Autumn J McRee, Salvatore Siena, Gary Middleton,[...]. Cancer Discov 2018
Ryan B Corcoran, Thierry André, Chloe E Atreya, Jan H M Schellens, Takayuki Yoshino, Johanna C Bendell, Antoine Hollebecque, Autumn J McRee, Salvatore Siena, Gary Middleton,[...]. Cancer Discov 2018
18
Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells.
István Szász, Viktória Koroknai, Tímea Kiss, Laura Vízkeleti, Róza Ádány, Margit Balázs. Melanoma Res 2019
István Szász, Viktória Koroknai, Tímea Kiss, Laura Vízkeleti, Róza Ádány, Margit Balázs. Melanoma Res 2019
28
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition.
Nikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, Dennie T Frederick, Zachary A Cooper, Amaro Taylor-Weiner, Mara Rosenberg, Eva M Goetz, Ryan J Sullivan, Deborah N Farlow,[...]. Cancer Discov 2014
Nikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, Dennie T Frederick, Zachary A Cooper, Amaro Taylor-Weiner, Mara Rosenberg, Eva M Goetz, Ryan J Sullivan, Deborah N Farlow,[...]. Cancer Discov 2014
18
Epigenetic changes of EGFR have an important role in BRAF inhibitor-resistant cutaneous melanomas.
Jinhua Wang, Sharon K Huang, Diego M Marzese, Sandy C Hsu, Neal P Kawas, Kelly K Chong, Georgina V Long, Alexander M Menzies, Richard A Scolyer, Sivan Izraely,[...]. J Invest Dermatol 2015
Jinhua Wang, Sharon K Huang, Diego M Marzese, Sandy C Hsu, Neal P Kawas, Kelly K Chong, Georgina V Long, Alexander M Menzies, Richard A Scolyer, Sivan Izraely,[...]. J Invest Dermatol 2015
18
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, Lidia Robert, Willy Hugo, Chunying Song, Xiangju Kong, Patricia A Possik, Paulien D M Cornelissen-Steijger, Marnix H Geukes Foppen,[...]. Nat Commun 2014
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, Lidia Robert, Willy Hugo, Chunying Song, Xiangju Kong, Patricia A Possik, Paulien D M Cornelissen-Steijger, Marnix H Geukes Foppen,[...]. Nat Commun 2014
18
Improved overall survival in melanoma with combined dabrafenib and trametinib.
Caroline Robert, Boguslawa Karaszewska, Jacob Schachter, Piotr Rutkowski, Andrzej Mackiewicz, Daniil Stroiakovski, Michael Lichinitser, Reinhard Dummer, Florent Grange, Laurent Mortier,[...]. N Engl J Med 2015
Caroline Robert, Boguslawa Karaszewska, Jacob Schachter, Piotr Rutkowski, Andrzej Mackiewicz, Daniil Stroiakovski, Michael Lichinitser, Reinhard Dummer, Florent Grange, Laurent Mortier,[...]. N Engl J Med 2015
18
Phenotype switching in melanoma: implications for progression and therapy.
Frederic Zhentao Li, Amardeep Singh Dhillon, Robin L Anderson, Grant McArthur, Petranel T Ferrao. Front Oncol 2015
Frederic Zhentao Li, Amardeep Singh Dhillon, Robin L Anderson, Grant McArthur, Petranel T Ferrao. Front Oncol 2015
18
Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.
Ross L Pearlman, Mary Katherine Montes de Oca, Harish Chandra Pal, Farrukh Afaq. Cancer Lett 2017
Ross L Pearlman, Mary Katherine Montes de Oca, Harish Chandra Pal, Farrukh Afaq. Cancer Lett 2017
18
Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.
Sunilkumar Kakadia, Naveen Yarlagadda, Ramez Awad, Madappa Kundranda, Jiaxin Niu, Boris Naraev, Lida Mina, Tomislav Dragovich, Mark Gimbel, Fade Mahmoud. Onco Targets Ther 2018
Sunilkumar Kakadia, Naveen Yarlagadda, Ramez Awad, Madappa Kundranda, Jiaxin Niu, Boris Naraev, Lida Mina, Tomislav Dragovich, Mark Gimbel, Fade Mahmoud. Onco Targets Ther 2018
18
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma.
Eliezer M Van Allen, Nikhil Wagle, Antje Sucker, Daniel J Treacy, Cory M Johannessen, Eva M Goetz, Chelsea S Place, Amaro Taylor-Weiner, Steven Whittaker, Gregory V Kryukov,[...]. Cancer Discov 2014
Eliezer M Van Allen, Nikhil Wagle, Antje Sucker, Daniel J Treacy, Cory M Johannessen, Eva M Goetz, Chelsea S Place, Amaro Taylor-Weiner, Steven Whittaker, Gregory V Kryukov,[...]. Cancer Discov 2014
18
Resistance to BRAF-targeted therapy in melanoma.
Ryan J Sullivan, Keith T Flaherty. Eur J Cancer 2013
Ryan J Sullivan, Keith T Flaherty. Eur J Cancer 2013
18
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).
Poulikos I Poulikakos, Yogindra Persaud, Manickam Janakiraman, Xiangju Kong, Charles Ng, Gatien Moriceau, Hubing Shi, Mohammad Atefi, Bjoern Titz, May Tal Gabay,[...]. Nature 2011
Poulikos I Poulikakos, Yogindra Persaud, Manickam Janakiraman, Xiangju Kong, Charles Ng, Gatien Moriceau, Hubing Shi, Mohammad Atefi, Bjoern Titz, May Tal Gabay,[...]. Nature 2011
18
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy.
Zeynep Eroglu, Antoni Ribas. Ther Adv Med Oncol 2016
Zeynep Eroglu, Antoni Ribas. Ther Adv Med Oncol 2016
18
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
Ramin Nazarian, Hubing Shi, Qi Wang, Xiangju Kong, Richard C Koya, Hane Lee, Zugen Chen, Mi-Kyung Lee, Narsis Attar, Hooman Sazegar,[...]. Nature 2010
Ramin Nazarian, Hubing Shi, Qi Wang, Xiangju Kong, Richard C Koya, Hane Lee, Zugen Chen, Mi-Kyung Lee, Narsis Attar, Hooman Sazegar,[...]. Nature 2010
18
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors.
Synnøve Nymark Aasen, Himalaya Parajuli, Tuyen Hoang, Zichao Feng, Krister Stokke, Jiwei Wang, Kislay Roy, Rolf Bjerkvig, Stian Knappskog, Frits Thorsen. Int J Mol Sci 2019
Synnøve Nymark Aasen, Himalaya Parajuli, Tuyen Hoang, Zichao Feng, Krister Stokke, Jiwei Wang, Kislay Roy, Rolf Bjerkvig, Stian Knappskog, Frits Thorsen. Int J Mol Sci 2019
18
Genetic progression of malignant melanoma.
J Tímár, L Vizkeleti, V Doma, T Barbai, E Rásó. Cancer Metastasis Rev 2016
J Tímár, L Vizkeleti, V Doma, T Barbai, E Rásó. Cancer Metastasis Rev 2016
18
Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies.
Stephen A Luebker, Scott A Koepsell. Front Oncol 2019
Stephen A Luebker, Scott A Koepsell. Front Oncol 2019
18
Gefitinib inhibits malignant melanoma cells through the VEGF/AKT signaling pathway.
Xuefeng Wan, Yalin Zhu, Lijuan Zhang, Wei Hou. Mol Med Rep 2018
Xuefeng Wan, Yalin Zhu, Lijuan Zhang, Wei Hou. Mol Med Rep 2018
18
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.
Benchun Miao, Zhenyu Ji, Li Tan, Michael Taylor, Jianming Zhang, Hwan Geun Choi, Dennie T Frederick, Raj Kumar, Jennifer A Wargo, Keith T Flaherty,[...]. Cancer Discov 2015
Benchun Miao, Zhenyu Ji, Li Tan, Michael Taylor, Jianming Zhang, Hwan Geun Choi, Dennie T Frederick, Raj Kumar, Jennifer A Wargo, Keith T Flaherty,[...]. Cancer Discov 2015
18
Somatic activation of KIT in distinct subtypes of melanoma.
John A Curtin, Klaus Busam, Daniel Pinkel, Boris C Bastian. J Clin Oncol 2006
John A Curtin, Klaus Busam, Daniel Pinkel, Boris C Bastian. J Clin Oncol 2006
18
Whole-genome landscapes of major melanoma subtypes.
Nicholas K Hayward, James S Wilmott, Nicola Waddell, Peter A Johansson, Matthew A Field, Katia Nones, Ann-Marie Patch, Hojabr Kakavand, Ludmil B Alexandrov, Hazel Burke,[...]. Nature 2017
Nicholas K Hayward, James S Wilmott, Nicola Waddell, Peter A Johansson, Matthew A Field, Katia Nones, Ann-Marie Patch, Hojabr Kakavand, Ludmil B Alexandrov, Hazel Burke,[...]. Nature 2017
18
Systematic synthesis of bisubstrate-type inhibitors of N-acetylglucosaminyltransferases.
Shinya Hanashima, Kei-ichiro Inamori, Shino Manabe, Naoyuki Taniguchi, Yukishige Ito. Chemistry 2006
Shinya Hanashima, Kei-ichiro Inamori, Shino Manabe, Naoyuki Taniguchi, Yukishige Ito. Chemistry 2006
9
Does glycosylation of melanoma cells influence their interactions with fibronectin?
A Litynska, M Przybylo, E Pochec, E Kremser, D Hoja-Lukowicz, U Sulowska. Biochimie 2006
A Litynska, M Przybylo, E Pochec, E Kremser, D Hoja-Lukowicz, U Sulowska. Biochimie 2006
9
N-glycans in cell survival and death: cross-talk between glycosyltransferases.
Dipak K Banerjee. Biochim Biophys Acta 2012
Dipak K Banerjee. Biochim Biophys Acta 2012
9
Membranous and Cytoplasmic Expression of PD-L1 in Ovarian Cancer Cells.
Qiu-Xia Qu, Fang Xie, Qin Huang, Xue-Guang Zhang. Cell Physiol Biochem 2017
Qiu-Xia Qu, Fang Xie, Qin Huang, Xue-Guang Zhang. Cell Physiol Biochem 2017
9
Advances in targeting epidermal growth factor receptor signaling pathway in mammary cancer.
Konstantina Kyriakopoulou, Elena Kefali, Zoi Piperigkou, Heba Bassiony, Nikos K Karamanos. Cell Signal 2018
Konstantina Kyriakopoulou, Elena Kefali, Zoi Piperigkou, Heba Bassiony, Nikos K Karamanos. Cell Signal 2018
9
N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc.
Yoshinobu Kariya, Rika Kato, Satsuki Itoh, Tomohiko Fukuda, Yukinao Shibukawa, Noriko Sanzen, Kiyotoshi Sekiguchi, Yoshinao Wada, Nana Kawasaki, Jianguo Gu. J Biol Chem 2008
Yoshinobu Kariya, Rika Kato, Satsuki Itoh, Tomohiko Fukuda, Yukinao Shibukawa, Noriko Sanzen, Kiyotoshi Sekiguchi, Yoshinao Wada, Nana Kawasaki, Jianguo Gu. J Biol Chem 2008
9
On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database.
R Apweiler, H Hermjakob, N Sharon. Biochim Biophys Acta 1999
R Apweiler, H Hermjakob, N Sharon. Biochim Biophys Acta 1999
9
Glycoprotein glycosylation and cancer progression.
J W Dennis, M Granovsky, C E Warren. Biochim Biophys Acta 1999
J W Dennis, M Granovsky, C E Warren. Biochim Biophys Acta 1999
9
CD147/basigin promotes progression of malignant melanoma and other cancers.
Takuro Kanekura, Xiang Chen. J Dermatol Sci 2010
Takuro Kanekura, Xiang Chen. J Dermatol Sci 2010
9
α2,6 sialylation associated with increased beta 1,6-branched N-oligosaccharides influences cellular adhesion and invasion.
Amit Ranjan, Rajiv D Kalraiya. J Biosci 2013
Amit Ranjan, Rajiv D Kalraiya. J Biosci 2013
9
Differential Toxicities of Tyrosine Kinase Inhibitors in the Management of Metastatic Lung Cancer.
Karthik S Udupa, Rejiv Rajendranath, Tenali Sagar, Joseph Thomas. Indian J Med Paediatr Oncol 2017
Karthik S Udupa, Rejiv Rajendranath, Tenali Sagar, Joseph Thomas. Indian J Med Paediatr Oncol 2017
33
PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules.
Qiaohong Geng, Peifu Jiao, Peng Jin, Gaoxing Su, Jinlong Dong, Bing Yan. Curr Pharm Des 2018
Qiaohong Geng, Peifu Jiao, Peng Jin, Gaoxing Su, Jinlong Dong, Bing Yan. Curr Pharm Des 2018
9
CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase.
Rie Nishibaba, Yuko Higashi, Juan Su, Tatsuhiko Furukawa, Kazuhiro Kawai, Takuro Kanekura. J Dermatol 2012
Rie Nishibaba, Yuko Higashi, Juan Su, Tatsuhiko Furukawa, Kazuhiro Kawai, Takuro Kanekura. J Dermatol 2012
9
Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels.
Jishun Lu, Tomoya Isaji, Sanghun Im, Tomohiko Fukuda, Akihiko Kameyama, Jianguo Gu. J Biol Chem 2016
Jishun Lu, Tomoya Isaji, Sanghun Im, Tomohiko Fukuda, Akihiko Kameyama, Jianguo Gu. J Biol Chem 2016
9
Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer.
Sonika Achalli, Medhini Madi, Subhas G Babu, Shishir Ram Shetty, Suchetha Kumari, Supriya Bhat. Indian J Dent Res 2017
Sonika Achalli, Medhini Madi, Subhas G Babu, Shishir Ram Shetty, Suchetha Kumari, Supriya Bhat. Indian J Dent Res 2017
10
Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor.
Kristin B Whitson, Stefanie R Whitson, Monica L Red-Brewer, Austin J McCoy, Angela A Vitali, Francesca Walker, Terrance G Johns, Albert H Beth, James V Staros. Biochemistry 2005
Kristin B Whitson, Stefanie R Whitson, Monica L Red-Brewer, Austin J McCoy, Angela A Vitali, Francesca Walker, Terrance G Johns, Albert H Beth, James V Staros. Biochemistry 2005
9
The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation.
Eric Lau, Yongmei Feng, Giuseppina Claps, Michiko N Fukuda, Ally Perlina, Dylan Donn, Lucia Jilaveanu, Harriet Kluger, Hudson H Freeze, Ze'ev A Ronai. Sci Signal 2015
Eric Lau, Yongmei Feng, Giuseppina Claps, Michiko N Fukuda, Ally Perlina, Dylan Donn, Lucia Jilaveanu, Harriet Kluger, Hudson H Freeze, Ze'ev A Ronai. Sci Signal 2015
9
Glycosylated CD147 reduces myocardial collagen cross-linking in cardiac hypertrophy.
Ning-Yu Ru, Long-Biao Cui, Bo Jiao, Lin Zhang, Shuai Jiang, Zhi-Bin Yu. J Cell Biochem 2018
Ning-Yu Ru, Long-Biao Cui, Bo Jiao, Lin Zhang, Shuai Jiang, Zhi-Bin Yu. J Cell Biochem 2018
25
The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer.
Heba Allam, Blake P Johnson, Mao Zhang, Zhongpeng Lu, Martin J Cannon, Karen L Abbott. J Biol Chem 2017
Heba Allam, Blake P Johnson, Mao Zhang, Zhongpeng Lu, Martin J Cannon, Karen L Abbott. J Biol Chem 2017
9
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.